Obesity in America: What the Latest CDC Data Shows
Over 40% of American adults have obesity according to the latest CDC data. Here is what the numbers show and why GLP-1 medications have become so important.
Obesity in America: The Data
Obesity is one of the most prevalent chronic health conditions in the United States. Here is what the latest government data tells us about the scope of the problem.
Current Prevalence
According to the CDC's National Center for Health Statistics (NCHS Data Brief No. 508), using data from the National Health and Nutrition Examination Survey (NHANES) collected between August 2021 and August 2023:
This means approximately 2 in 5 American adults are living with obesity.
State-Level Data
The CDC's Behavioral Risk Factor Surveillance System (BRFSS) provides state-by-state data:
*Source: CDC "Adult Obesity Prevalence Maps," updated 2024.*
Health Consequences
Obesity increases the risk of numerous serious health conditions, as documented by the CDC:
Economic Impact
The medical costs associated with obesity are substantial. The CDC estimates that obesity-related medical costs in the United States are significant, with people with obesity paying higher medical costs than those at a healthy weight.
Why GLP-1 Medications Matter
The approval of effective GLP-1 medications represents a shift in how obesity is treated medically. Before semaglutide and tirzepatide, available weight loss medications produced relatively modest results (typically 5-10% weight loss). The current generation of GLP-1 medications produces 15-22% average weight loss in clinical trials, approaching the outcomes of some bariatric surgical procedures.
However, significant barriers to access remain:
The Bigger Picture
Obesity is now recognized by major medical organizations including the American Medical Association as a chronic, relapsing disease -- not simply a matter of willpower. GLP-1 medications, combined with lifestyle modifications, represent an important tool in addressing this public health challenge.
*This article presents publicly available data from the CDC and peer-reviewed medical literature. It is for educational purposes and does not constitute medical advice.*
Cite This Article
DoseLean Medical Team. (April 28, 2026). Obesity in America: What the Latest CDC Data Shows. DoseLean. https://doselean.com/learn/obesity-statistics-america-cdc-data
DoseLean Medical Team. "Obesity in America: What the Latest CDC Data Shows." DoseLean, April 28, 2026, https://doselean.com/learn/obesity-statistics-america-cdc-data
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider before starting any weight loss program or medication.
Published: April 13, 2026
Last Updated: April 28, 2026